IP Library Granted Patent US 8,753,845
Granted Patent B2
US 8,753,845 · App. 12/979,899 · Granted Jun 17, 2014

Thermostable reverse transcriptases and uses thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,753,845
App. No.
12/979,899
Granted
Jun 17, 2014
Kind
B2
Abstract

The present invention is in the fields of molecular and cellular biology. The invention is generally related to reverse transcriptase enzymes and methods for the reverse transcription of nucleic acid molecules, especially messenger RNA molecules. Specifically, the invention relates to reverse transcriptase enzymes which have been mutated or modified to increase thermostability, decrease terminal deoxynucleotidyl transferase activity, and/or increase fidelity, and to methods of producing, amplifying or sequencing nucleic acid molecules (particularly cDNA molecules) using these reverse transcriptase enzymes or compositions. The invention also relates to nucleic acid molecules produced by these methods and to the use of such nucleic acid molecules to produce desired polypeptides. The invention also concerns kits comprising such enzymes or compositions.

Claims (4)

1. A method for making one or more nucleic acid molecules comprising mixing one or more nucleic acid templates with one or more polypeptides having reverse transcriptase activity wherein the reverse transcriptase is an M-MLV reverse transcriptase comprising amino acids 34-710 of SEQ ID NO: 2 and incubating the mixture under conditions sufficient to synthesize one or more first nucleic acid molecules complementary to all or at least a portion of the one or more nucleic acid templates.

2. The method of claim 1 , wherein the one more nucleic acid templates are RNA.

3. The method of claim 2 , wherein the nucleic acid templates are mRNA.

4. The method of claim 1 , wherein the synthesized molecule is labeled.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 11, 2013
From: SMITH, MICHAEL D.; POTTER, ROBERT JASON; DHARIWAL, GULSHAN; GERARD, GARY F.; ROSENTHAL, KIM; LEE, JUN
To: INVITROGEN CORPORATION
Reel/Frame 029789/0341 →
MERGER Recorded Feb 11, 2013
From: INVITROGEN CORPORATION
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 029789/0435 →